Volume 1, Issue 2 (Autumn – Winter 2008[PERSIAN] 2007)                   mljgoums 2007, 1(2): 0-0 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mofidi M, Saeedi M, Behnampoor N. Sero-epidemiologic investigation of Herpes Simplex virus type II in Gorgan, 2005. mljgoums 2007; 1 (2)
URL: http://mlj.goums.ac.ir/article-1-69-en.html
1- Instructor of Immunology Golestan , Mofidi_h@yahoo.com
Abstract:   (22525 Views)

Abstract Background and objectives: Herpes simplex virus type two (HSV-2) infections are mostly considered as a sexually transmitted disease. It causes genital herpes, newborn herpes non-pyrogenic meningitis and may act as an underlying factor for HIV infection. This study was conducted to determine the sero-epidemiologic prevalence of herpes simplex virus type two in cases referred to ten clinical laboratories of Gorgan. Materials and methods: This cross- sectional study was performed on blood Samples of 406 randomly selected Clients. These samples were analyzed for Anti HSV-2 using Specific enzyme-Linked immunoassays (ELIZA) Results: Four point nine percent of all subjects have anti HSV-2. There is Significant difference between sero-positive HSV-2 and factors such as age and Marital Status (P<0.05). Conclusion: HIV is progressively increased and HSV-2 infection is one of the major risk factors for HIV therefore, decreasing the prevalence of HSV-2 infections may Leads to the reduction of HIV prevalence. Key word: HSV-2, Antibody, Gorgan, Sero-epidemiology.


Received: 2011/09/4 | Accepted: 2014/01/12 | Published: 2014/01/12 | ePublished: 2014/01/12

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.